Table 3.
PowerPlan use and systemic corticosteroid therapy
| Variables | Usual care group (n=178) | PowerPlan used (n=72) | Point difference (95% CI) | P-value |
|---|---|---|---|---|
| Cumulative total corticosteroid dose,a mg | 611±462 | 420±224 | 191 (99 to 281) | <0.001 |
| Cumulative intravenous SC dose,a mg | 471±397 | 246±146 | 225 (135 to 312) | <0.001 |
| Cumulative oral SC dose,a mg | 323±190 | 245±109 | 78 (36 to 118) | <0.001 |
| Duration of intravenous SC, days | 3.2±1.9 | 2.2±1.2 | 1.0 (0.4 to 1.4) | <0.001 |
| Duration of total corticosteroid use, days | 13.0±15.6 | 9.6±5.5 | 3.4 (-0.3 to 7.1) | 0.075 |
| Duration of outpatient corticosteroids prescribed at the time of discharge, days | 6.9±6.3 | 5.1±4.6 | 1.8 (0.3 to 1.3) | 0.018 |
Notes: Data are expressed as mean±SD.
a
All steroid doses are expressed as prednisone equivalent doses.
Abbreviation: SC, systemic corticosteroids.